carbidopa - CISMeF

Preferred Label : carbidopa;

MeSH definition : An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.; An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself.;

MeSH synonym : methyldopahydrazine;

MeSH hyponym : lodosin; MK-486; MK-485; MK 486; MK486; Lodosyn; MK 485; MK485;

Related MeSH term : Carbidopa, (S)-Isomer; carbidopa, (R)-Isomer;

MeSH CAS label : benzenepropanoic acid, alpha-hydrazino-3,4-dihydroxy-alpha-methyl-, monohydrate, (S)-;

MeSH Related Number : carbidopa, (R)-Isomer; carbidopa, (S)-Isomer; 28860-95-9 ((S)-isomer); 28875-92-5 ((R)-isomer); 38821-49-7 (Carbidopa);

Registry Number MeSH : 38821-49-7;

Related CAS MeSH : 28875-92-5 (Carbidopa, (R)-Isomer); 28860-95-9 (Carbidopa, (S)-Isomer);

Wikipedia link : https://en.wikipedia.org/wiki/Carbidopa;

Codes EINECS : 249-271-9;

Is substance : O;

UNII : MNX7R8C5VO;

InChIKey : QTAOMKOIBXZKND-PPHPATTJSA-N;

Details

Origin ID

D002230;

UMLS CUI

C0006982;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Carbidopa measurement (procedure) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Carbidopa [LOINC component]
- Carbidopa [NCIt concept]
- Carbidopa (substance) [SNOMED CT concept]
- carbidopa [SNOMED Notion]
- carbidopa [Substance BNPC]
Pharmacological action(s)
- Aromatic Amino Acid Decarboxylase Inhibitors [MeSH Descriptor]
- dopamine agents [MeSH Descriptor]
Record concept(s)
- Carbidopa, (S)-Isomer [MeSH concept]
- MK-485 [MeSH concept]
- MK-486 [MeSH concept]
- carbidopa [MeSH concept]
- carbidopa, (R)-Isomer [MeSH concept]
- lodosin [MeSH concept]
Related MeSH Supplementary Concept(s)
- Stalevo [MeSH Supplementary Concept]
- carbidopa, levodopa drug combination [MeSH Supplementary Concept]
- sirio [MeSH Supplementary Concept]
See also (suggested by CISMeF)
- dopa decarboxylase [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Carbidopa [LOINC component]
- Carbidopa [NCIt concept]
- Carbidopa (substance) [SNOMED CT concept]
- Product containing carbidopa (medicinal product) [SNOMED CT concept]
- carbidopa [Substance BNPC]
- carbidopa [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients